ProciseDx Announces $13 Million Convertible Note Financing and Strong International Growth
Summary
said President and CFO, Peter Westlake, "This funding round enables us to move forward with FDA submissions for the platform and to expand our test menu for gastroenterologists." ProciseDx has established distribution relationships in more than 15 countries in Europe, Middle East and Africa (EMEA) and expects to continue its market expansion for the rest of 2021. Founded by experienced IVD specialists with a track record of successfully launching innovative Point of Care platforms, ProciseDx tests have a turn-around time of only 2-5 minutes and are easy, quantitative and accurate. Founded in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 225 employees, the French laboratory Biosynex designs, manufactures and distributes Rapid Diagnostic Tests (TDRs). Biosynex is the leader in the TDR market in France and is the only player to fully control its value chain thanks to its technology platform, which can be used in a variety of applications and is adapted to different types of users such as laboratories, hospitals, doctors and the general public.